Join the Oncology Voice Network. Join for Free
Positive Mindset = Positive Outcomes
Positive mindset overcoming negativity bias mindfulness techniques mindset-driven recovery positive habits

Positive Mindset = Positive Outcomes


Share This Article


Summary

In this episode, Don Sandel from Go Positive joins Tom Caravela to explore the power of a positive mindset. They delve into the science behind positivity, introducing the DOSE acronym and discussing the effects of overcoming negativity bias. Don shares techniques for fostering positivity through relationships, self-talk, and mindfulness. The conversation includes practical tips on meditation, choosing happiness, and using technology and exercise to build positive habits. They emphasize the importance of accountability and a supportive social environment. The episode wraps up with inspiring stories of mindset-driven recovery and a note of gratitude.

This weeks MSL Talk podcast guest is Don Sandel, the Founder, speaker, and facilitator at GoPositiv and best-selling author and performance coach who shares research-based solutions for adopting a positive mindset which leads to positive outcomes.

Don shares…

👉 What led him to write his book “Positive Mindshift”
👉 What is most important for people when it comes to mindset
👉 How people can break the habit of negativity bias
👉 What ways we can shift our thoughts and retrain our brain
👉 What kind of daily habits and mindset techniques we can adopt each day

Click for Source
Positive mindset, overcoming negativity bias, mindfulness techniques, mindset-driven recovery, positive habits

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Things will be HARD…but YOU can do hard things!
Partner Avatar MSL Talk: Tom Caravela

Things will be HARD…but YOU can do hard things!

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Article
Expert perspectives live from ASCO® 2025
Partner Avatar iNIZIO

Expert perspectives live from ASCO® 2025

Article
Where Did My Interview Go Wrong?
Partner Avatar Tom Caravela

Where Did My Interview Go Wrong?

Explore OVN